CN Patent

CN101175477A — 碘塞罗宁的控释药物组合物及其制备和使用方法

Assigned to King Pharmaceuticals Research and Development Inc · Expires 2008-05-07 · 18y expired

What this patent protects

本发明涉及包含碘塞罗宁(liothyronine)、或其盐或衍生物的缓释药物组合物。此外，本发明还涉及本发明药物组合物的制备方法和使用方法。

USPTO Abstract

本发明涉及包含碘塞罗宁(liothyronine)、或其盐或衍生物的缓释药物组合物。此外，本发明还涉及本发明药物组合物的制备方法和使用方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101175477A
Jurisdiction
CN
Classification
—
Expires
2008-05-07
Drug substance claim
No
Drug product claim
No
Assignee
King Pharmaceuticals Research and Development Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.